A detailed history of Israel Englander (Millennium Management LLC) transactions in Lava Therapeutics Nv stock. As of the latest transaction made, Millennium Management LLC holds 26,493 shares of LVTX stock, worth $50,336. This represents 0.0% of its overall portfolio holdings.

Number of Shares
26,493
Previous 20,028 32.28%
Holding current value
$50,336
Previous $66,000 28.79%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.8 - $3.37 $11,637 - $21,787
6,465 Added 32.28%
26,493 $47,000
Q1 2024

May 15, 2024

SELL
$1.53 - $4.03 $12,293 - $32,381
-8,035 Reduced 28.63%
20,028 $66,000
Q4 2023

Feb 14, 2024

SELL
$1.17 - $1.58 $61,203 - $82,651
-52,311 Reduced 65.08%
28,063 $44,000
Q2 2023

Aug 14, 2023

BUY
$1.4 - $2.6 $112,523 - $208,972
80,374 New
80,374 $163,000
Q3 2022

Nov 14, 2022

SELL
$2.34 - $4.75 $133,946 - $271,899
-57,242 Reduced 59.38%
39,163 $179,000

Others Institutions Holding LVTX

About LAVA Therapeutics NV


  • Ticker LVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,797,700
  • Market Cap $49M
  • Description
  • LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...
More about LVTX
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.